Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

NCT00145925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

11140

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Perindopril-indapamide
DRUG: Gliclazide MR-based glucose lowering

Sponsor

The George Institute

Collaborators

[object Object]
[object Object]
[object Object]